The Blood Cancer United Specialized Center of Research (SCOR) Program 2026–2027 supports multidisciplinary teams pursuing integrated research to develop new approaches for the treatment, diagnosis, and prevention of hematologic malignancies.
The program is specifically designed to connect established investigators across disciplines and institutions, with a strong emphasis on moving discoveries from the laboratory toward clinical application.
For the 2026–2027 cycle, one SCOR award will focus specifically on myelodysplastic syndromes (MDS) through a partnership between Blood Cancer United and the Edward P. Evans Foundation, while a second award will prioritize T-cell lymphoma, myeloproliferative neoplasms, multiple myeloma, or pediatric leukemia.
Eligibility Criteria
- Applications are open worldwide to appropriate academic institutions and investigators of any nationality.
- Applicants and SCOR key personnel must hold a PhD, MD, DVM, or equivalent degree.
- Applicants must be affiliated with a nonprofit institution when funding begins and throughout the award.
- Projects may involve investigators from one or multiple institutions.
- Each SCOR must include 3–5 scientific Projects.
- Each SCOR must include one Administrative Core.
- The SCOR Director must serve as Project Leader for one proposed Project.
Funding Details
- Maximum Award: $5,000,000
- Duration: 5 years
- Maximum Annual Award: $1,000,000 per year
- Maximum Annual Indirect Costs: $150,000
Deadline
- Call for Proposals: September 18, 2026
- LOI Deadline: December 8, 2026, at 3:00 PM EST
- Full Application Invitation: January 19, 2027
- Full Application Deadline: March 30, 2027, at 3:00 PM EDT
- Award Notification: July 2027
- Funding Start Date: October 1, 2027
Further Information
- Applications are submitted through the Blood Cancer United Research Portal. Applicants should review the current SCOR Guidelines and Instructions and the application template before beginning the submission.
- Blood Cancer United — Specialized Center of Research Program — official program page with the current FY2027 deadlines, funding structure, eligibility, FAQs, and application documents.
- Blood Cancer United Research Portal — official portal for submitting the LOI and, if invited, the full application.